OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
Germana Castelli, Elvira Pelosi, Ugo Testa
Cancers (2017) Vol. 9, Iss. 9, pp. 127-127
Open Access | Times Cited: 144
Germana Castelli, Elvira Pelosi, Ugo Testa
Cancers (2017) Vol. 9, Iss. 9, pp. 127-127
Open Access | Times Cited: 144
Showing 1-25 of 144 citing articles:
Tumour evolution in hepatocellular carcinoma
Amanda J. Craig, Johann von Felden, Teresa García‐Lezana, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 17, Iss. 3, pp. 139-152
Closed Access | Times Cited: 681
Amanda J. Craig, Johann von Felden, Teresa García‐Lezana, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 17, Iss. 3, pp. 139-152
Closed Access | Times Cited: 681
The Curious Case of the HepG2 Cell Line: 40 Years of Expertise
Viktoriia A. Arzumanian, Olga I. Kiseleva, Ekaterina V. Poverennaya
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13135-13135
Open Access | Times Cited: 215
Viktoriia A. Arzumanian, Olga I. Kiseleva, Ekaterina V. Poverennaya
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13135-13135
Open Access | Times Cited: 215
Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 154
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 154
Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy
О. Ф. Гордеева
Seminars in Cancer Biology (2018) Vol. 53, pp. 75-89
Closed Access | Times Cited: 106
О. Ф. Гордеева
Seminars in Cancer Biology (2018) Vol. 53, pp. 75-89
Closed Access | Times Cited: 106
Aldehyde Dehydrogenase, Liver Disease and Cancer
Wenjun Wang, Chunguang Wang, Hongxin Xu, et al.
International Journal of Biological Sciences (2020) Vol. 16, Iss. 6, pp. 921-934
Open Access | Times Cited: 105
Wenjun Wang, Chunguang Wang, Hongxin Xu, et al.
International Journal of Biological Sciences (2020) Vol. 16, Iss. 6, pp. 921-934
Open Access | Times Cited: 105
AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation
Xinyu Bian, Dongmin Shi, Kailin Xing, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 3
Open Access | Times Cited: 60
Xinyu Bian, Dongmin Shi, Kailin Xing, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 3
Open Access | Times Cited: 60
S-Adenosylmethionine: From the Discovery of Its Inhibition of Tumorigenesis to Its Use as a Therapeutic Agent
Rosa M. Pascale, Maria M. Simile, Diego F. Calvisi, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 409-409
Open Access | Times Cited: 48
Rosa M. Pascale, Maria M. Simile, Diego F. Calvisi, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 409-409
Open Access | Times Cited: 48
Anticancer Potential of Apigenin and Isovitexin with Focus on Oncogenic Metabolism in Cancer Stem Cells
Maryam Ghanbari-Movahed, Sahar Shafiee, Jack T. Burcher, et al.
Metabolites (2023) Vol. 13, Iss. 3, pp. 404-404
Open Access | Times Cited: 25
Maryam Ghanbari-Movahed, Sahar Shafiee, Jack T. Burcher, et al.
Metabolites (2023) Vol. 13, Iss. 3, pp. 404-404
Open Access | Times Cited: 25
Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice
Lu Zong, Hui Peng, Cheng Sun, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 67
Lu Zong, Hui Peng, Cheng Sun, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 67
Macrophages Are a Double-Edged Sword: Molecular Crosstalk between Tumor-Associated Macrophages and Cancer Stem Cells
Shahang Luo, Guanghui Yang, Peng Ye, et al.
Biomolecules (2022) Vol. 12, Iss. 6, pp. 850-850
Open Access | Times Cited: 34
Shahang Luo, Guanghui Yang, Peng Ye, et al.
Biomolecules (2022) Vol. 12, Iss. 6, pp. 850-850
Open Access | Times Cited: 34
The Role of the Ectopeptidase APN/CD13 in Cancer
Uwe Lendeckel, Farzaneh Karimi, Ruba Al‐Abdulla, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 724-724
Open Access | Times Cited: 17
Uwe Lendeckel, Farzaneh Karimi, Ruba Al‐Abdulla, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 724-724
Open Access | Times Cited: 17
Identification of SPP1+ macrophages in promoting cancer stemness via vitronectin and CCL15 signals crosstalk in liver cancer
Yizhou Wang, Qing Wang, Shuangfen Tao, et al.
Cancer Letters (2024) Vol. 604, pp. 217199-217199
Open Access | Times Cited: 8
Yizhou Wang, Qing Wang, Shuangfen Tao, et al.
Cancer Letters (2024) Vol. 604, pp. 217199-217199
Open Access | Times Cited: 8
Characterization of lymphocyte‐rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures
Bokyung Ahn, Hee‐Sung Ahn, Jin-Ho Shin, et al.
Liver International (2024) Vol. 44, Iss. 5, pp. 1202-1218
Open Access | Times Cited: 7
Bokyung Ahn, Hee‐Sung Ahn, Jin-Ho Shin, et al.
Liver International (2024) Vol. 44, Iss. 5, pp. 1202-1218
Open Access | Times Cited: 7
A comprehensive review of phytoconstituents in liver cancer prevention and treatment: targeting insights into molecular signaling pathways
Md. Rezaul Islam, Abdur Rauf, Shopnil Alash, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 7
Md. Rezaul Islam, Abdur Rauf, Shopnil Alash, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 7
MiR-186-5p prevents hepatocellular carcinoma progression by targeting methyltransferase-like 3 that regulates m6A-mediated stabilization of follistatin-like 5
Shuoshuo Ma, Fangfang Chen, Chuanle Lin, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26767-e26767
Open Access | Times Cited: 6
Shuoshuo Ma, Fangfang Chen, Chuanle Lin, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26767-e26767
Open Access | Times Cited: 6
MicroRNA-1305 Inhibits the Stemness of LCSCs and Tumorigenesis by Repressing the UBE2T-Dependent Akt-Signaling Pathway
Xiao-Yong Wei, Xiaolong You, Jianlong Zhang, et al.
Molecular Therapy — Nucleic Acids (2019) Vol. 16, pp. 721-732
Open Access | Times Cited: 52
Xiao-Yong Wei, Xiaolong You, Jianlong Zhang, et al.
Molecular Therapy — Nucleic Acids (2019) Vol. 16, pp. 721-732
Open Access | Times Cited: 52
Deranged hepatocyte intracellular Ca2+ homeostasis and the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma
Eunüs S. Ali, Grigori Y. Rychkov, Greg J. Barritt
Cell Calcium (2019) Vol. 82, pp. 102057-102057
Closed Access | Times Cited: 52
Eunüs S. Ali, Grigori Y. Rychkov, Greg J. Barritt
Cell Calcium (2019) Vol. 82, pp. 102057-102057
Closed Access | Times Cited: 52
Curcumin and Photobiomodulation in Chronic Viral Hepatitis and Hepatocellular Carcinoma
Laura Marinela Ailioaie, Gerhard Litscher
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7150-7150
Open Access | Times Cited: 50
Laura Marinela Ailioaie, Gerhard Litscher
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7150-7150
Open Access | Times Cited: 50
Exosomes derived from HBV‑associated liver cancer promote chemoresistance by upregulating chaperone‑mediated autophagy
Dian‐Xing Liu, Peng‐Peng Li, Jiapei Guo, et al.
Oncology Letters (2018)
Open Access | Times Cited: 49
Dian‐Xing Liu, Peng‐Peng Li, Jiapei Guo, et al.
Oncology Letters (2018)
Open Access | Times Cited: 49
Hypoxia-induced myeloid derived growth factor promotes hepatocellular carcinoma progression through remodeling tumor microenvironment
Xu Wang, Jie Mao, Tao Zhou, et al.
Theranostics (2020) Vol. 11, Iss. 1, pp. 209-221
Open Access | Times Cited: 42
Xu Wang, Jie Mao, Tao Zhou, et al.
Theranostics (2020) Vol. 11, Iss. 1, pp. 209-221
Open Access | Times Cited: 42
Mechanisms by Which Probiotic Bacteria Attenuate the Risk of Hepatocellular Carcinoma
Wasitha P. D. W. Thilakarathna, H.P. Vasantha Rupasinghe, Neale D. Ridgway
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2606-2606
Open Access | Times Cited: 40
Wasitha P. D. W. Thilakarathna, H.P. Vasantha Rupasinghe, Neale D. Ridgway
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2606-2606
Open Access | Times Cited: 40
TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway
Lei Li, Tao Wang, Shanbao Li, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 39
Lei Li, Tao Wang, Shanbao Li, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 39
NIPBL::NACC1 Fusion Hepatic Carcinoma
Erika Hissong, Majd Al Assaad, Munita Bal, et al.
The American Journal of Surgical Pathology (2023) Vol. 48, Iss. 2, pp. 183-193
Closed Access | Times Cited: 14
Erika Hissong, Majd Al Assaad, Munita Bal, et al.
The American Journal of Surgical Pathology (2023) Vol. 48, Iss. 2, pp. 183-193
Closed Access | Times Cited: 14
Understanding the inflammation-cancer transformation in the development of primary liver cancer
Hongjin Chen, Minghua Hu, Fanggui Xu, et al.
Hepatoma Research (2018) Vol. 4, Iss. 7, pp. 29-29
Open Access | Times Cited: 39
Hongjin Chen, Minghua Hu, Fanggui Xu, et al.
Hepatoma Research (2018) Vol. 4, Iss. 7, pp. 29-29
Open Access | Times Cited: 39
Targeting AMP ‐activated kinase impacts hepatocellular cancer stem cells induced by long‐term treatment with sorafenib
Alicia Bort, Belén G. Sánchez, Pedro A. Mateos‐Gómez, et al.
Molecular Oncology (2019) Vol. 13, Iss. 5, pp. 1311-1331
Open Access | Times Cited: 38
Alicia Bort, Belén G. Sánchez, Pedro A. Mateos‐Gómez, et al.
Molecular Oncology (2019) Vol. 13, Iss. 5, pp. 1311-1331
Open Access | Times Cited: 38
